One in every eight women will be diagnosed with breast cancer in her lifetime. That’s a sobering statistic, and it’s one that compels members of Vanderbilt Population Health’s Quality Impact Specialists (QIS) Team to motivate patients to get their annual breast cancer screenings. By pairing new technology strategies with more efficient communications, last year the team achieved dramatic results in the number of patients scheduled for these screenings. Read the full article to find best practices your staff can use to increase screening appointments and meet this important quality benchmark.

During the COVID-19 pandemic, the Department of Health and Human Services (HHS) waived or modified health regulations to better equip hospitals, primary care clinics and other care settings to help prevent and treat cases of COVID-19. Many of these waivers were tied to the Public Health Emergency (PHE), which is set to expire on May 11, 2023.

On April 12, VHAN held a Town Hall to discuss the implications of unwinding from the PHE, as well as ways you can adjust to these changes and sustain quality patient care with minimal interruptions. Read the full article for key takeaways and additional resources that can help you with the PHE expiration.

The March 27 shooting at the Covenant School in Nashville was devastating for all of us, especially those in the middle Tennessee communities served by you, our VHAN members. Our thoughts are with the loved ones of the victims, the first responders and all of those who are struggling with the impact of this traumatic event.

In the aftermath, we turn our attention to our young patients, particularly those in need of counseling and other behavioral health services. Read the full article to access behavioral health tools and resources for pediatric patients and their families.

Signed into law in August 2022, the Inflation Reduction Act (IRA) includes provisions to lower health care and medication costs over the next several years. This article outlines a few key implications of which providers should be aware.

The way we practiced health care a decade ago is barely recognizable today. But VHAN has successfully navigated this sea change over the past 10 years by keeping our eye on what matters most—improved care delivery, better outcomes and true health equity.

In recent years the VHAN Population Health Pharmacy Team has made it a priority to help patients, particularly ones with chronic illnesses, improve compliance to their prescriptions. This focus on medication adherence not only helps patients better manage their chronic diseases, but it also helps maintain consistent medical care during transitions and even reduce drug costs. It’s all part of the team’s efforts to produce better patient outcomes.

In recent months, demand for GLP1 (glucagon like peptide 1) receptor agonists has skyrocketed across the country, leaving providers inundated with prescription requests and patients frustrated with shortages. GLP1 agonists have an important place in obesity therapy. However, there are many unanswered questions about long-term side effects, cost-effectiveness and the duration of therapy. Unfortunately, current manufacturing cannot adequately meet the demand for both diabetes and obesity treatment. The VHAN Pharmacy Team has the following recommendations for navigating ongoing shortages.

One of our key goals has been to develop a systematic approach to identify and review utilization patterns, trends and variation in care that impact quality outcomes and costs across VHAN.

Last month the Biden-Harris administration announced that the COVID-19 Public Health Emergency (PHE) will end on May 11. This will have large impacts on Medicare ACO programs as well as TennCare recipients. Read the full article for a few items that members should be aware of.